0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.52%
Negative revenue growth while 3606.HK stands at 5.72%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.64%
Negative gross profit growth while 3606.HK is at 16.09%. Joel Greenblatt would examine cost competitiveness or demand decline.
-43.49%
Negative EBIT growth while 3606.HK is at 7.11%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-40.57%
Negative operating income growth while 3606.HK is at 12.79%. Joel Greenblatt would press for urgent turnaround measures.
-82.23%
Negative net income growth while 3606.HK stands at 17.64%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-80.89%
Negative EPS growth while 3606.HK is at 16.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-82.21%
Negative diluted EPS growth while 3606.HK is at 16.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-7.43%
Share reduction while 3606.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.01%
Diluted share change of 0.01% while 3606.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
364.22%
Positive OCF growth while 3606.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
237.08%
Positive FCF growth while 3606.HK is negative. John Neff would see a strong competitive edge in net cash generation.
75929.25%
10Y revenue/share CAGR above 1.5x 3606.HK's 494.63%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
33.05%
5Y revenue/share CAGR under 50% of 3606.HK's 153.30%. Michael Burry would suspect a significant competitive gap or product weakness.
4.30%
3Y revenue/share CAGR under 50% of 3606.HK's 28.44%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
2432.89%
10Y OCF/share CAGR above 1.5x 3606.HK's 581.70%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-19.33%
Negative 5Y OCF/share CAGR while 3606.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
78.77%
3Y OCF/share CAGR of 78.77% while 3606.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
170.51%
Below 50% of 3606.HK's 591.84%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
118.16%
Below 50% of 3606.HK's 270.58%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
158.20%
3Y net income/share CAGR above 1.5x 3606.HK's 26.45%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
240.50%
5Y equity/share CAGR above 1.5x 3606.HK's 155.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
102.05%
3Y equity/share CAGR above 1.5x 3606.HK's 36.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
No Data
No Data available this quarter, please select a different quarter.
72.56%
Inventory growth well above 3606.HK's 5.01%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.91%
Negative asset growth while 3606.HK invests at 3.35%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
9.36%
1.25-1.5x 3606.HK's 7.87%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
24.71%
We have some new debt while 3606.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-71.23%
Our R&D shrinks while 3606.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.54%
We expand SG&A while 3606.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.